Glen Santangelo
Stock Analyst at Barclays
(3.33)
# 1,056
Out of 5,113 analysts
111
Total ratings
54.67%
Success rate
1.74%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Overweight | $26 → $24 | $16.55 | +45.02% | 3 | Dec 16, 2025 | |
| ZTS Zoetis | Initiates: Equal-Weight | $136 | $122.24 | +11.26% | 2 | Dec 9, 2025 | |
| XERS Xeris Biopharma Holdings | Initiates: Overweight | $9 | $7.34 | +22.62% | 3 | Dec 9, 2025 | |
| VTRS Viatris | Initiates: Overweight | $15 | $11.93 | +25.73% | 5 | Dec 9, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Overweight | $35 | $30.35 | +15.32% | 5 | Dec 9, 2025 | |
| TDOC Teladoc Health | Initiates: Equal-Weight | $8.5 | $7.23 | +17.57% | 8 | Dec 9, 2025 | |
| TARS Tarsus Pharmaceuticals | Initiates: Overweight | $100 | $81.40 | +22.85% | 1 | Dec 9, 2025 | |
| TALK Talkspace | Initiates: Equal-Weight | $3.5 | $3.55 | -1.41% | 2 | Dec 9, 2025 | |
| PGNY Progyny | Initiates: Overweight | $29 | $26.63 | +8.90% | 5 | Dec 9, 2025 | |
| PHAT Phathom Pharmaceuticals | Initiates: Equal-Weight | $16 | $17.53 | -8.73% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $27 | $26.35 | +2.47% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $86 | $77.35 | +11.18% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $118 | $95.50 | +23.56% | 7 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $3 | $2.77 | +8.30% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $22.28 | +7.72% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $22.30 | +34.53% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $63 | $43.65 | +44.33% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $12 | $11.21 | +7.05% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $58 | $48.88 | +18.66% | 4 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $400 | $340.93 | +17.33% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $243 | $202.95 | +19.73% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $8 | $6.88 | +16.28% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $100 | $82.85 | +20.70% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $30 | $26.60 | +12.78% | 3 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $12.57 | +19.33% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $38.21 | +28.24% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $5 | $4.90 | +2.04% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $170 | $157.69 | +7.81% | 2 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $7.5 | $6.83 | +9.81% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $960 | $820.25 | +17.04% | 6 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $850 | $700.34 | +21.37% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $35.56 | +34.98% | 5 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $32.84 | +55.30% | 1 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $7.82 | +1,178.77% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $42.02 | +30.89% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.35 | +1,091.49% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $4.66 | +2,475.11% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.54 | +1,317.32% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $77.72 | - | 3 | Mar 17, 2021 |
Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26 → $24
Current: $16.55
Upside: +45.02%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $122.24
Upside: +11.26%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.34
Upside: +22.62%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $11.93
Upside: +25.73%
Teva Pharmaceutical Industries
Dec 9, 2025
Initiates: Overweight
Price Target: $35
Current: $30.35
Upside: +15.32%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $7.23
Upside: +17.57%
Tarsus Pharmaceuticals
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $81.40
Upside: +22.85%
Talkspace
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.55
Upside: -1.41%
Progyny
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $26.63
Upside: +8.90%
Phathom Pharmaceuticals
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $17.53
Upside: -8.73%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $27
Current: $26.35
Upside: +2.47%
Dec 9, 2025
Initiates: Overweight
Price Target: $86
Current: $77.35
Upside: +11.18%
Dec 9, 2025
Initiates: Overweight
Price Target: $118
Current: $95.50
Upside: +23.56%
Dec 9, 2025
Initiates: Underweight
Price Target: $3
Current: $2.77
Upside: +8.30%
Dec 9, 2025
Initiates: Overweight
Price Target: $24
Current: $22.28
Upside: +7.72%
Dec 9, 2025
Initiates: Overweight
Price Target: $30
Current: $22.30
Upside: +34.53%
Dec 9, 2025
Initiates: Overweight
Price Target: $63
Current: $43.65
Upside: +44.33%
Dec 9, 2025
Initiates: Underweight
Price Target: $12
Current: $11.21
Upside: +7.05%
Dec 9, 2025
Initiates: Overweight
Price Target: $58
Current: $48.88
Upside: +18.66%
Dec 9, 2025
Initiates: Overweight
Price Target: $400
Current: $340.93
Upside: +17.33%
Dec 9, 2025
Initiates: Overweight
Price Target: $243
Current: $202.95
Upside: +19.73%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8
Current: $6.88
Upside: +16.28%
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $82.85
Upside: +20.70%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $30
Current: $26.60
Upside: +12.78%
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $12.57
Upside: +19.33%
Dec 9, 2025
Initiates: Overweight
Price Target: $49
Current: $38.21
Upside: +28.24%
Dec 9, 2025
Initiates: Underweight
Price Target: $5
Current: $4.90
Upside: +2.04%
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $170
Current: $157.69
Upside: +7.81%
Dec 9, 2025
Initiates: Underweight
Price Target: $7.5
Current: $6.83
Upside: +9.81%
Dec 9, 2025
Initiates: Overweight
Price Target: $960
Current: $820.25
Upside: +17.04%
Dec 9, 2025
Initiates: Overweight
Price Target: $850
Current: $700.34
Upside: +21.37%
Dec 9, 2025
Initiates: Overweight
Price Target: $48
Current: $35.56
Upside: +34.98%
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $32.84
Upside: +55.30%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $7.82
Upside: +1,178.77%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $42.02
Upside: +30.89%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.35
Upside: +1,091.49%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $4.66
Upside: +2,475.11%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.54
Upside: +1,317.32%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $77.72
Upside: -